↓ Skip to main content

Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants

Overview of attention for article published in Cochrane database of systematic reviews, March 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

blogs
1 blog
twitter
2 tweeters
facebook
2 Facebook pages

Citations

dimensions_citation
50 Dimensions

Readers on

mendeley
160 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants
Published in
Cochrane database of systematic reviews, March 2013
DOI 10.1002/14651858.cd003951.pub3
Pubmed ID
Authors

Manoj N Malviya, Arne Ohlsson, Sachin S Shah

Abstract

A patent ductus arteriosus (PDA) with significant left to right shunt increases morbidity and mortality in preterm infants. Early closure of the ductus arteriosus may be achieved pharmacologically or by surgery. The preferred initial treatment of a symptomatic PDA, surgical ligation or treatment with indomethacin, is not clear.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 160 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Germany 1 <1%
Canada 1 <1%
South Africa 1 <1%
Unknown 156 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 31 19%
Student > Bachelor 24 15%
Student > Postgraduate 18 11%
Researcher 17 11%
Student > Ph. D. Student 15 9%
Other 37 23%
Unknown 18 11%
Readers by discipline Count As %
Medicine and Dentistry 99 62%
Nursing and Health Professions 13 8%
Pharmacology, Toxicology and Pharmaceutical Science 8 5%
Agricultural and Biological Sciences 4 3%
Social Sciences 2 1%
Other 10 6%
Unknown 24 15%

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 October 2014.
All research outputs
#1,059,754
of 12,527,219 outputs
Outputs from Cochrane database of systematic reviews
#3,120
of 8,923 outputs
Outputs of similar age
#14,293
of 146,346 outputs
Outputs of similar age from Cochrane database of systematic reviews
#36
of 118 outputs
Altmetric has tracked 12,527,219 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 146,346 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 118 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.